Mercados españoles cerrados

ICON Public Limited Company (ICLR)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
312,05+2,54 (+0,82%)
A partir del 11:35AM EDT. Mercado abierto.

ICON Public Limited Company

South County Business Park
Leopardstown
Dublin D18 X5R3
Ireland
353 1 291 2000
https://www.iconplc.com

Sector(es)Healthcare
SectorDiagnostics & Research
Empleados a tiempo completo41.150

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Dr. Steven A. Cutler MBA, Ph.D.CEO & Director2,59MN/A1960
Dr. John Climax Ph.D.Founder & Independent Non-Executive Director90kN/A1953
Mr. Brendan BrennanChief Financial Officer1,07MN/A1979
Jonathan Andrew CurtainSenior Vice President of Corporate & Commercial FinanceN/AN/A1976
Mr. Thomas N. O'LearyChief Information OfficerN/AN/AN/A
Mr. Diarmaid CunninghamChief Administrative Officer, General Counsel & Company SecretaryN/AN/A1975
Ms. Niamh MurphyDirector of Corporate CommunicationsN/AN/AN/A
Mr. David GreenVice President of MarketingN/AN/AN/A
Mr. Joe CroninChief Human Resources OfficerN/AN/AN/A
Mr. Simon HolmesPresident of Corporate Investments & PartnershipsN/AN/A1967
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Gobierno corporativo

El ISS Governance QualityScore de ICON Public Limited Company, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.